DE69734984D1 - Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten - Google Patents

Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten

Info

Publication number
DE69734984D1
DE69734984D1 DE69734984T DE69734984T DE69734984D1 DE 69734984 D1 DE69734984 D1 DE 69734984D1 DE 69734984 T DE69734984 T DE 69734984T DE 69734984 T DE69734984 T DE 69734984T DE 69734984 D1 DE69734984 D1 DE 69734984D1
Authority
DE
Germany
Prior art keywords
treatment
combination
receptor antagonists
respiratory tract
allergic reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69734984T
Other languages
English (en)
Inventor
William Kreutner
A Hey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69734984D1 publication Critical patent/DE69734984D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69734984T 1996-08-16 1997-08-13 Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten Expired - Lifetime DE69734984D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (1)

Publication Number Publication Date
DE69734984D1 true DE69734984D1 (de) 2006-02-02

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734984T Expired - Lifetime DE69734984D1 (de) 1996-08-16 1997-08-13 Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten

Country Status (25)

Country Link
EP (1) EP0920315B1 (de)
JP (2) JP3638289B2 (de)
KR (1) KR20000029975A (de)
CN (1) CN1152682C (de)
AR (1) AR008293A1 (de)
AT (1) ATE314071T1 (de)
AU (1) AU722040B2 (de)
BR (1) BR9711149A (de)
CA (1) CA2263163A1 (de)
CO (1) CO4910138A1 (de)
CZ (1) CZ43299A3 (de)
DE (1) DE69734984D1 (de)
HU (1) HUP9904362A3 (de)
ID (1) ID17871A (de)
IL (1) IL128573A0 (de)
MY (1) MY116130A (de)
NO (1) NO990706D0 (de)
NZ (1) NZ334063A (de)
PE (1) PE100298A1 (de)
PL (1) PL191073B1 (de)
SK (1) SK20099A3 (de)
TR (1) TR199900326T2 (de)
TW (2) TW200427450A (de)
WO (1) WO1998006394A1 (de)
ZA (1) ZA977263B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517472A (en) * 1997-03-26 2003-08-29 Sepracor Inc Lactose free norastemizole formulations with improved stability
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
EP1028948B1 (de) * 1997-11-07 2003-01-29 Schering Corporation Phenyl-alkyl imidazole als h3 rezeptor antagonisten
WO1999024421A1 (en) * 1997-11-07 1999-05-20 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
DE69806042T2 (de) * 1997-11-07 2003-01-23 Schering Corp., Kenilworth Phenylalkyl imidazole derivate als h3 rezeptor liganden
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
CN1329490A (zh) * 1998-10-09 2002-01-02 先灵公司 用于治疗变应性疾病的组合物和方法
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
AU7589700A (en) * 1999-09-22 2001-04-24 Schering Corporation Treating allergic and inflammatory conditions
MXPA02007558A (es) 2000-02-03 2002-12-13 Schering Corp Tratamiento de condiciones inflamatorias alergicas.
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
MY131890A (en) 2001-03-13 2007-09-28 Schering Corp Piperidine compounds
AU2003223631B2 (en) 2002-04-18 2006-07-20 Schering Corporation 1-(4-Piperidinyl) benzimidazolones as histamine H3 antagonists
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
AU2003243709B2 (en) 2002-06-24 2007-01-18 Schering Corporation Indole derivatives useful as histamine H3 antagonists
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
ES2337727T3 (es) 2005-06-20 2010-04-28 Schering Corporation Derivados de piperidina utiles como antagonistas de histamina h3.
WO2010027567A2 (en) 2008-07-23 2010-03-11 Schering Corporation Tricyclic spirocycle derivatives and methods of use thereof
EP2350048A2 (de) 2008-10-16 2011-08-03 Schering Corporation Azinderivate und verfahren zu deren anwendung
US8283360B2 (en) 2008-12-19 2012-10-09 Merck Sharp & Dohme Corp. Bicyclic heterocyclic derivatives and methods of use thereof
WO2010071822A1 (en) 2008-12-19 2010-06-24 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
PT2408453T (pt) 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US9399032B2 (en) * 2009-05-14 2016-07-26 The General Hospital Corporation Methods and compositions for treating degenerative and ischemic disorders
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
NO990706L (no) 1999-02-15
KR20000029975A (ko) 2000-05-25
AU722040B2 (en) 2000-07-20
IL128573A0 (en) 2000-01-31
ID17871A (id) 1998-02-05
CO4910138A1 (es) 2000-04-24
CZ43299A3 (cs) 1999-07-14
JP3638289B2 (ja) 2005-04-13
HUP9904362A3 (en) 2000-12-28
TR199900326T2 (xx) 1999-05-21
EP0920315A1 (de) 1999-06-09
CN1233179A (zh) 1999-10-27
PL191073B1 (pl) 2006-03-31
PE100298A1 (es) 1999-01-11
MY116130A (en) 2003-11-28
JP2003095979A (ja) 2003-04-03
TW200427450A (en) 2004-12-16
ATE314071T1 (de) 2006-01-15
CA2263163A1 (en) 1998-02-19
CN1152682C (zh) 2004-06-09
HUP9904362A2 (hu) 2000-11-28
NO990706D0 (no) 1999-02-15
NZ334063A (en) 2000-09-29
AR008293A1 (es) 1999-12-29
ZA977263B (en) 1998-02-16
TWI221768B (en) 2004-10-11
BR9711149A (pt) 1999-08-17
AU3973397A (en) 1998-03-06
WO1998006394A1 (en) 1998-02-19
SK20099A3 (en) 2000-08-14
PL331617A1 (en) 1999-08-02
EP0920315B1 (de) 2005-12-28
JP2000505094A (ja) 2000-04-25

Similar Documents

Publication Publication Date Title
DE69734984D1 (de) Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten
EP0230370A3 (en) Use of specific n-methyl-d-aspartate receptor antagonists in the prevention and treatment of neurodegeneration
DE60033947D1 (de) Dosierungsform und verfahren zu einer effektiven reboxetintherapie mit einer "einmal täglich" dosierung
CY2015056I1 (el) Ανασυνδυασμενοι antαγωνιστες της il-5 που ειναι χρησιμοι στη θεραπεια διαταραχων που διαμεσολαβουνται απο την il-5
ITRM940356A0 (it) "perfezionamento nei sistemi stimolatori cardiaci".-
DE69733775D1 (de) Titandioxidteilchen mit verklebenden diskreten anorganischen teilchen
DE69526704D1 (de) Mit modifizierten Polysiloxan beschichtete anorganische Teilchen
FI963511A (fi) Pakko-oireisten häiriöiden hoito 5-HT2-antagonisteilla
NO975976D0 (no) Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
HUP0105490A3 (en) Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
MA23172A1 (fr) Antagonistes de recepteurs d'endotheline .
IL111379A0 (en) Histamine h3-receptor antagonists and therapeutic uses thereof
DE19653645A1 (de) Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
Horlacher Metric Irregularity in" Les noces": The Problem of Periodicity
DE59811722D1 (de) Abbildende und/oder abtastende vorrichtung mit einer kompensierung von, durch die umgebung verursachter abbildungsverschlechterungen
DE69133390D1 (de) Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall
DE3774737D1 (de) Abschaltbares halbleiterbauelement sowie verwendung desselben.
NO892542D0 (no) Fremgangsmaate for fremstilling av neurokinin a antagonister.
DE69125175D1 (de) Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen
NO20020008D0 (no) Anvendelse av cortisol antagonister i behandling av hjertesvikt
NO953050L (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
DE69600374D1 (de) Zubereitung in Form von einer weichen Paste und Herstellungsverfahren
DE69801173D1 (de) Gerät zur Rettung und Bergung von ins Wasser gefallenen Personen
DE59503551D1 (de) Vorrichtung zur diskontinuierlichen zubereitung von teigwaren und portioniervorrichtung zur verwendung mit einer solchen vorrichtung
DK210587A (da) Biocide midler, samt anvendelse deraf

Legal Events

Date Code Title Description
8332 No legal effect for de